Objective: To describe the epidemiological, clinical and prognosis aspects of tetanus in patients hospitalized at the Infectious and Tropical Diseases Unit of Treichville Teaching Hospital.
INTRODUCTION
Tetanus is a serious, accidental, non-contagious toxi-infection that does not confer immunity and is caused by Clostridium tetani, with a strong disparity in the world. Since the Dakar conference which established its prognosis criteria used in sub-Saharan Africa since 1975 [1] , and despite the 1995 World Health Organization's (WHO) stated intention to eradicate tetanus in childbearing, it remains a severe endemic infectious disease, responsible for nearly one million deaths per year in developing countries [2] .
In Côte d'Ivoire, the immunization schedule recommended for children consists of three vaccine injections at 6, 10 and 14 weeks of life. A vaccine booster dose is given at 16 months, at 6 and half years, at 11 and half years, and then every 10 years. For adolescent or adult subjects not vaccinated during childhood, the tetanus vaccine is recommended on the 1st day, and then 1 month and 6 months or 12 months later. A booster shot is given every 10 years. For women not vaccinated, the immunization schedule consists of a 1st dose of tetanus vaccine at the 1st visit regardless of age, followed by a 2nd dose one month after the 1st one. The booster shot is given six months after the last injection, the 2nd one is given one year after the last injection and the 3rd and last one is also given 1 year after the last injection. [3, 4] . Moreover, recent African studies showed a trend towards increased incidence of tetanus in adults [4] [5] [6] [7] [8] . Hence the present study aimed at describing the current aspects of tetanus in patients admitted to the referral tetanus care unit, the Infectious and Tropical Diseases Unit (ITDU) at Treichville Teaching Hospital, Abidjan, over a period of ten years (2005-2014) while reporting the current features of poor prognosis [4, 9, 10] . 
METHODS

Study design and setting
Study population
All patients with generalized or localized tetanus, admitted at ITDU from 1st January 2005 to 31st December 2014 were included.
Data collection
A standardized survey form was completed from patients' records and included Sociodemographic, clinical and treatment histories.
Diagnosis of tetanus
The diagnosis of tetanus was based on the presence of following clinical signs: (i) presence of trismus (difficulty of mouth opening) or permanent painful muscle contractions with or without paroxysms; (ii) no disorders of consciousness (coma, obnubilation) [4] [5] [6] [7] [8] ; (iii) point of entry such as skin injuries according to "the Dakar Prognosis Score" [1, 4, 5, 7, 10] ;.
Statistical Analysis
Quantitative variables were described in terms of median and interquartile range. Categorical variables were described in terms of numbers and percentage. Tetanus prevalence was estimated with its 95% confidence interval. The comparison of median was made using the Kruskal-Wallis test and that of qualitative variables using the Chi-square test or the Fisher's exact test according to theoretical numbers. A multivariate logistic regression model was used to identify factors associated with death. Data were analyzed using Stata 9.0 software.
RESULTS
Socio-demographic data
A total of 6988 patients were admitted to ITDU during the study period, including 467 (6.7%; 95 CI 6.1-7.3) cases of tetanus from which 12 were excluded because of incomplete data. Among the 455 cases of tetanus enrolled, 390 patients (85.7%) were male. Their median age was 41 years [IQR: 1-80] and the most affected age group was the ones between 15 and 60 years.
Patients were predominantly of Ivorian nationality (58.6%), and most of them were living in urban zone: Abidjan district (76.9%). The occupations most represented were liberal professions (small businesses at risk of skin excoriations: hairdressers, scrap merchants, masons, carpenters, cleaners etc.) (53.3%), followed by workers (14.1%) and the unemployed (13.9%). The majority of patients (93%) had no tetanus immunization coverage.
Clinical Findings
The main symptoms observed at admission were reported in Table 2 . Muscle contractions (100.0%), trismus (92.7%) and paroxysms (80.2%) were the predominant symptoms. The incubation period was greater than or equal to 7 days in the majority of cases (73.1%) and the invasion period was less than 2 days in 66.3% of patients. A total of 435 patients had generalized tetanus and 20 patients had localized tetanus.
Main sites of entry
The sites of entry were known for 404 patients (88.8%). These were in the lower limbs in 304 cases (75.2%), on the face in 21 cases (5.2%), in the upper limbs 41 cases (10.2%) and finally on the head in 38 cases (9.4%).
Among patients whose sites of entry were found, those scored 1 according to "the Dakar prognosis score" predominantly consisted of intramuscular injections (n=22; 4.8%), surgeries (n=13; 2.9%), fractures (n=8; 1.8%). The other sites of entry (scored 0) were the most observed in the study with 360 cases (79.1%) ( Table 3) .
Treatment history
Upon hospitalization, most of our tetanus patients received antibiotics, 429 cases (94.3%) because of over infected site of entry and sepsis in sub-Saharan Africa context. Among the treated patients, 388 received antibiotic monotherapy (85.3%) versus 41 cases which were treated with two antibiotics (9.0%). Penicillin G 100 000 IU/kg per day in continuous intravenous was the most prescribed in 382 cases (83.9%). It was replaced by metronidazole (500 mg three times intravenous) in 12 cases (2.6%) for allergic reaction to penicillin G. Patients with complications or over infection of the site of entry received a second-line amoxicillin/clavulanic acid combination therapy plus gentamycin in 164 cases (36%).
The daily treatment of the site of entry consisted in disinfection, cleaning and excision. Intrathecal serotherapy was performed with 1500 IU of heterologous antitetanus serum of equine origin combined with 25 mg of hydrocortisone hemisuccinate. Maintaining the hydro-electrolytic and caloric balance was done with continuous infusions of crystalloid solutions (hypertonic and isotonic glucoses, saline and Ringer's lactate). The sedation of contractions was based on intravenous infusions of diazepam at a dose of 1-2 mg/kg/day, sometimes combined with phenobarbital at a dose of 5-20 µg/kg in known drug-addicted patients.
Hospital stay ranged from 1 to 48 days depending on complications with a median of 10 days.
Evolution and complications
The 455 patients were divided into three groups according to "the Dakar prognosis score": 145 cases of Mild tetanus (score 0-1), 31.8%; 251 cases of moderate tetanus (score 2-3), 55.2% and 59 cases of severe tetanus (score 4-6), 13.0%.
Some complications were observed in 254 patients (55.8%). These were infectious complications characterized as severe sepsis and infections associated with treatment in 100 cases (38.4%) and severe malaria in 22 cases (8.6%). Neurological complications were observed in 32 patients (12.5%), particularly subintrant paroxysms. As for respiratory complications, they included respiratory distress in 24 cases (9.4%) and pulmonary superinfection in 21 cases (8.2%). Finally, 10 cases of high blood pressure crisis were reported among cardiovascular complications (3.9%).
Patient outcomes
In the 455 patients, 318 were discharged alive from the hospital (69.9%). Among the alive ones, there were 296 cases of healing (93.1%) including 201 without sequels; 10 were referred to other services for additional care and 12 (2.6%) discharged themselves from the hospitalization unit against medical advice.
Factors associated with death or severity
The analysis of death-associated factors demonstrates that patients most at risk of dying were: (Table 4): •Those over 60 years of age (aOR 2.76 : 95% CI 1.07-9.91),
•Workers and labour force (aOR=2.83, 95% CI 1.07-9.39),
•Those with a severe Dakar prognosis score (aOR=5.76, 95% CI 2.26-14.72),
•Those who did not received intrathecal injection (aOR=15.6, 95% CI 5.40-44.84),
•Those who did not received penicillin-therapy (aOR=2.33; 95% CI 1.11-4.87) and those with complication (aOR=8.53, 95% CI 4.83-15.09).
DISCUSSION
Tetanus remains an endemic disease in Abidjan with an average annual prevalence of 47 ± 10 cases, slightly above that reported by Aba et al. [5] , but below those found by Tanon et al. [4] and Kakou et al. [7] in studies conducted more than 10 years ago in the same Unit [4, 5, 7] . This overall decrease in the prevalence of tetanus could be explained by the management of some cases of juvenile tetanus by paediatric services, whereas previously, tetanus cases were mostly referred to ITDU, on the one hand, and by proper awareness and tetanus On socio demographical aspects, there was a male dominance of tetanus incident cases with a M/F sex ratio = 6, similar to that reported by Aba et al. [5] in Abidjan, but above those reported by Seydi et al. [12] in Dakar (Senegal) and Minta et al. [8] in Bamako (Mali) which were 4.3 and 2.41 respectively. This is evidence that the tetanus eradication policy through immunization for women of childbearing age, as advocated by WHO campaigns in all resource-limited countries, virtually works well.
The sites of entry were many, varied and dominated by the cutaneous ones, as in other African studies [6, 9, 12, 13] . However, the proportions of the sites of entry scored 1 according to "the Dakar score" (intramuscular injections, umbilicus, burn, uterus, surgery and fracture) remain significant, with a grade always severe in our study; thus, health professionals' awareness must be raised when providing care in order to prevent or reduce these cases of iatrogenic tetanus [14] [15] [16] [17] [18] [19] . The proportion of generalized tetanus cases in our study remains high (95.6%), as demonstrated in most studies conducted in Côte d'Ivoire, Mali, Senegal, and Congo [4, 6, 8, 12, 20] .
As regards patient outcomes, 3.8% were discharged against the treating physicians' advice, more often for lack of financial resources, whereas Aba et al. recorded 10.4% [5] . This variation could be explained by better awareness-raising among patients' relatives by physicians, on the one hand, and the slow resumption of professional activities since the end of the post-electoral crisis in 2011 in Côte d'Ivoire, on the other hand.
The median duration of hospital stays in our study was 7 days [1 and 28 days], similar to that found in Mali and Senegal [6, 8, 12] . The inhospital mortality rate related to tetanus was 30% over 10 years in our study. This is also similar to those of Aba et al. [5] (29.9%) and Tanon et al. [4] (32.0%) in the same service, but lower than that reported in Congo (37.50%) [16, 20] , whereas Seydi et al. [12] found only 22% in Senegal. The mortality rate was higher in the most active age group (20-55 years) with 71%, and predominantly greater among men (86%), more often due to the presence of complications or disease severity. Sometimes the lack of financial resources among some J Microbiol Infect Dis www.jmidonline.org Vol 7, No 3, September 2017 patients led to insufficient treatment and care, which were responsible for early deaths [12] .
The univariate and multivariate analysis of prognosis factors significantly associated with death revealed that age >60 years, high-risk workers' occupations, presence of complications especially respiratory distress and the lack of intrathecal serotherapy and antibiotherapy (Penicillin-G) were significantly associated with death, apart from the poor prognosis features in the Dakar score [9, 18] . These results are similar to those of other studies in other countries. Indeed, a study conducted in Turkey in 1997 also showed that older age was associated with death among 88 adult patients with tetanus [21] . Also, the administration of intrathecal serotherapy made it possible to considerably reduce (94%) mortality in our study. This practice, which aims to neutralize the circulating toxin in the nervous system that has not penetrated the neurons yet, demonstrated a reduction in mortality from 30% to 93% depending on the doses administrated in the previous studies [22] [23] [24] [25] . Thus, intrathecal serotherapy could be recommended in countries with no specific human tetanus immunoglobin. Conversely, HIV positive status, male sex and liberal professions or crafts did not appear as pejorative features (p-value not significant). This study highlighted the need to conduct a multicentre study in the affected countries, in order to integrate new parameters in determining the real tetanus' prognosis score.
In our study, the majority of patients were not vaccinated". These results are similar to those reported in most of the Sub-Saharan Africa studies [4, 5, [8] [9] [10] [11] [12] [13] 19] . These results emphasize the importance of catch-up immunization or vaccination in adolescents or adults not vaccinated during childhood.
Finally, as any study with a retrospective component, ours has some limitations. Furthermore, some data were collected only based on the verbal reports of patients and/or their accompanying persons; this was particularly the case for the immunization status, because most of our hospitalized patients did not have vaccination records. In spite of these limitations noticed, the sample size and the long duration of our study allowed us to collect relevant data on the current aspects of tetanus and its treatment in Abidjan.
Tetanus remains an endemic disease with high in-hospital mortality in Côte d'Ivoire. Tetanus vaccine, although effective, is available free of charge only for women of childbearing age and children under 11 months of age, as part of the Ivorian EPI. This has tremendously reduced morbidity in this portion of the population. However, the latter as well as older populations remain the most vulnerable ones with an alarming death rate.
It therefore seems appropriate to revisit the prognosis parameters in "the Dakar score" so as to adapt them to the current epidemiological and clinical contexts in resources limited settings.
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